Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig N Robson

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
Discovery Medicine|October 1, 2009
Targeting alternative splicing in prostate oncologyPhillippa J Carling, David J Elliott, Craig N Robson, et al.
Journal of Cell Science|March 24, 2006
KGF suppresses alpha2beta1 integrin function and promotes differentiation of the transient amplifying population in human prostatic epitheliumRakesh Heer, Anne T Collins, Craig N Robson, et al.
The Prostate|March 26, 2004
Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancerKalipso Halkidou, Luke Gaughan, Susan Cook, et al.
Journal of Virology|September 6, 2005
Inhibition of ubiquitination and stabilization of human ubiquitin E3 ligase PIRH2 by measles virus phosphoproteinMingzhou Chen, Jean-Claude Cortay, Ian R Logan, et al.
The Prostate|April 19, 2007
Analysis of the MDM2 antagonist nutlin-3 in human prostate cancer cellsIan R Logan, Hesta V McNeill, Susan Cook, et al.
Oncotarget|September 5, 2015
FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancerDominic Jones, Mark Wade, Sirintra Nakjang, et al.
Plos One|January 26, 2013
p68/DdX5 supports β-catenin & RNAP II during androgen receptor mediated transcription in prostate cancerEmma L Clark, Christiana Hadjimichael, Richard Temperley, et al.
Oncogene|July 12, 2023
Engineering prostate cancer in vitro: what does it take?Adriana Buskin, Emma Scott, Ryan Nelson, et al.
Nucleic Acids Research|December 10, 2014
The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancerMark A Wade, Dominic Jones, Laura Wilson, et al.
Molecular and Cellular Biology|August 18, 2006
Human PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancerIan R Logan, Luke Gaughan, Stuart R C McCracken, et al.
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
Discovery Medicine|October 1, 2009
Targeting alternative splicing in prostate oncologyPhillippa J Carling, David J Elliott, Craig N Robson, et al.
Journal of Cell Science|March 24, 2006
KGF suppresses alpha2beta1 integrin function and promotes differentiation of the transient amplifying population in human prostatic epitheliumRakesh Heer, Anne T Collins, Craig N Robson, et al.
The Prostate|March 26, 2004
Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancerKalipso Halkidou, Luke Gaughan, Susan Cook, et al.
Journal of Virology|September 6, 2005
Inhibition of ubiquitination and stabilization of human ubiquitin E3 ligase PIRH2 by measles virus phosphoproteinMingzhou Chen, Jean-Claude Cortay, Ian R Logan, et al.
The Prostate|April 19, 2007
Analysis of the MDM2 antagonist nutlin-3 in human prostate cancer cellsIan R Logan, Hesta V McNeill, Susan Cook, et al.
Oncotarget|September 5, 2015
FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancerDominic Jones, Mark Wade, Sirintra Nakjang, et al.
Plos One|January 26, 2013
p68/DdX5 supports β-catenin & RNAP II during androgen receptor mediated transcription in prostate cancerEmma L Clark, Christiana Hadjimichael, Richard Temperley, et al.
Oncogene|July 12, 2023
Engineering prostate cancer in vitro: what does it take?Adriana Buskin, Emma Scott, Ryan Nelson, et al.
Nucleic Acids Research|December 10, 2014
The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancerMark A Wade, Dominic Jones, Laura Wilson, et al.
Molecular and Cellular Biology|August 18, 2006
Human PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancerIan R Logan, Luke Gaughan, Stuart R C McCracken, et al.
Pageof 10